BEDU-ADDO FRANK 4
4 · PDS Biotechnology Corp · Filed Jan 20, 2022
Insider Transaction Report
Form 4
BEDU-ADDO FRANK
DirectorPresident/CEO
Transactions
- Award
Stock Option (Right to Buy)
2022-01-19−291,500→ 291,500 totalExercise: $6.28Exp: 2032-01-19→ Common Stock (291,500 underlying)
Footnotes (1)
- [F1]This option, representing a right to purchase a total of 291,500 shares of Common Stock, will become exercisable on January 19, 2023, with 25% vesting on that date and the remaining vesting in equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date, until fully vested on January 19, 2026.